Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy

American Journal of Kidney Diseases

Volumn 33, Issue 5, 1999, Pages 851-856

  Russo, D ^a   Pisani, A ^a   Balletta, M M ^a   De Nicola, L ^a   Savino, F A ^a   Andreucci, M ^a   Minutolo, R ^a  

^a NONE   (Italy)

Author keywords

Converting enzyme inhibitors; IgA nephropathy; Losartan; Proteinuria

Indexed keywords

CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN; PROTEIN; SODIUM;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CREATININE CLEARANCE; DRUG EFFECT; DRUG POTENTIATION; FEMALE; HEMATOCRIT; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; MALE; MUSCLE WEAKNESS; PROTEIN URINE LEVEL; PROTEINURIA; SODIUM URINE LEVEL;

EID: 0032905797     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(99)70416-6     Document Type: Article

References (17)

1. G Maschio D Alberti G Janin F Locatelli JFE Mann M Motolese C Ponticelli E Ritz P Zucchelli Effect of the angiotensin-converting enzyme inhibitor benazepril on the progression of chronic renal insufficiency N Engl J Med 334 1996 939 945
2. DC Cattran C Greenwood S Ritchie Long-term benefits of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin A nephropathy: A comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapy Am J Kidney Dis 23 1994 247 254
3. M Ravid R Lang R Rachmani M Lishner Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non–insulin-dependent diabetes mellitus Arch Intern Med 156 1996 286 289
4. JC Peterson S Adler JM Burkart T Greene LA Hebert L Hunsicker A King S Khlar SG Massry JL Seifter Blood pressure control, proteinuria and the progression of renal disease Ann Intern Med 123 1995 754 762
5. T Matsusaka J Hymes I Ichikawa Angiotensin in progressive renal diseases. Theory and practice J Am Soc Nephrol 7 1996 2025 2043
6. PF Mento BM Wilkes Plasma angiotensins and blood pressure during converting enzyme inhibition Hypertension 9 suppl 3 1987 S42 S48
7. J Biollatz HR Brunner I Gavras B Weaber H Gavras Antihypertensive therapy with MK-421: Angiotensin II–renin relationship to evaluate efficacy of converting enzyme inhibition J Cardiovasc Pharmacol 4 1982 966 972
8. H Urata KD Bohem A Philip A Kinoshita J Gabrovsek M Bumpus A Husain Cellular localization and regional distribution of an angiotensin II–forming chymase in the heart J Clin Invest 91 1993 1269 1281
9. A Remuzzi E Perticucci P Ruggenenti L Mosconi M Limonta G Remuzzi Angiotensin-converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy Kidney Int 39 1991 1267 1273
10. D Russo R Minutolo B Cianciaruso B Memoli G Conte L De Nicola Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure J Am Soc Nephrol 6 1995 1451 1458
11. The GISEN Group Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy Lancet 349 1997 1857 1863
12. JE Heeg PE de Jong GK Van Der Hem D de Zeeuw Reduction of proteinuria by angiotensin-converting enzyme inhibition Kidney Int 32 1987 78 83
13. M Azizi TT Guyene G Chatellier M Wargon J Ménard Additive effects of losartan and enalapril on blood pressure and plasma active renin Hypertension 29 1997 634 640
14. M Burnier B Rutschumann J Nussberger J Versaggi S Shainfar B Waeber HR Brunner Salt-dependent renal effects of an angiotensin II antagonist in healthy subjects Hypertension 22 1993 339 347
15. M Burnier M Hagman J Nussberger J Biollaz C Armagnac R Brouard B Waeber HR Brunner Short-term and sustained renal effects of angiotensin II receptor blockade in healthy subjects Hypertension 25 1995 602 609
16. MR Goldberg W Tanaka A Berchowsky TE Bradstreet J McCrea MW Lo EJ McWilliams TD Djornsson Effects of losartan on blood pressure, plasma renin activity, and angiotensin II in volunteers Hypertension 21 1993 704 713
17. RT Gansevoort D De Zeeuw PE De Jong Is the anti-proteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system? Kidney Int 45 1994 861 867